Zevra Therapeutics Free Cash Flow (Quarterly) Analysis

Zevra Therapeutics Inc (ZVRA)

4.87 +0.14 (+2.85%) USD | NASDAQ | May 03, 13:41

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-16.23M
September 30, 2023	-4.80M
June 30, 2023	-8.727M
March 31, 2023	-4.074M
December 31, 2022	-4.496M
September 30, 2022	-6.626M
June 30, 2022	-4.119M
March 31, 2022	-3.569M
December 31, 2021	-0.865M
September 30, 2021	-2.734M
June 30, 2021	16.52M
March 31, 2021	-2.586M
December 31, 2020	-1.085M
September 30, 2020	-1.051M
June 30, 2020	2.197M
March 31, 2020	-2.033M
December 31, 2019	-3.103M
September 30, 2019	-2.233M
June 30, 2019	-7.344M
March 31, 2019	-11.08M

Date	Value
December 31, 2018	-15.01M
September 30, 2018	-15.96M
June 30, 2018	-9.152M
March 31, 2018	-14.10M
December 31, 2017	-6.939M
September 30, 2017	-10.20M
June 30, 2017	-6.517M
March 31, 2017	-9.62M
December 31, 2016	-9.449M
September 30, 2016	-8.608M
June 30, 2016	-8.427M
March 31, 2016	-3.931M
December 31, 2015	-6.443M
September 30, 2015	-4.666M
June 30, 2015	-5.274M
March 31, 2015	-4.02M
December 31, 2014	-6.991M
September 30, 2014	-3.894M
June 30, 2014	-2.941M
March 31, 2014	-0.892M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-16.23M

Minimum

Dec 2023

16.52M

Maximum

Jun 2021

-2.998M

Average

-3.103M

Median

Dec 2019

Free Cash Flow (Quarterly) Benchmarks